Prevent Blindness, the nation's leading patient advocacy organization dedicated to preventing blindness and preserving sight, ...

SEATTLE -- Diabetic patients treated with GLP-1 agonists had significantly more progression of existing diabetic eye disease as compared with those treated with SGLT2 inhibitors, a matched cohort ...

November is Diabetes-related Eye Disease Awareness Month, and early detection and treatment of diabetes are key to reduce the risk for significant vision loss and blindness, according to Prevent ...

Conflicting studies on GLP-1 drugs’ vision impacts prompt calls for baseline eye exams and monitoring.

In their separate studies, Jakob Grauslund, Professor of Ophthalmology, and Anton Pottegård, Professor of Pharmaceuticals, have used two different methods to investigate all Danish users of Ozempic.

Men are at greater risk than women of the major health effects of diabetes (types 1 and 2), suggests a long term study published online in the Journal of Epidemiology & Community Health. Rates of ...